Alexandru Stieber/LinkedIn
Dec 18, 2025, 13:34
Alexandru Stieber Explores VEXAS Syndrome
Alexandru Stieber, Internal Medicine Resident at SUUMC Bucharest, shared on LinkedIn:
”Second set of scientific updates from the SNFMI Congress that took place last week in Tours, France.
The theme of today’s post revolves around VEXAS syndrome, new implications for patients with a VEXAS-like phenotype and the evolving concept of “clonal hematopoiesis of immunological significance” (CHIS).
- proven efficacy of azacitidine treatment in VEXAS patients, even in the absence of myelodysplastic syndrome
- proven pathophysiology of UBA1 mutated myeloid cells that drive an inflammatory millieu which alters normal hematopoiesis
- new links found between clonalhematopoiesis with IDH mutations and inflammatory manifestations (polymyalgia rheumatica and large-vessel vasculitis), with resolution under targeted inhibitors”
Stay updated with Hemostasis Today.
-
Apr 7, 2026, 16:06Mohamed Elsafy։ Rethinking Hemostatic Management in Glanzmann Thrombasthenia with Sutacimig
-
Apr 7, 2026, 16:03Frits Rosendaal Is The 2026 Recipient of the ISTH Robert P. Grant Medal
-
Apr 7, 2026, 16:02Support the WHO Resolution On Stroke and Set A Clear Path to Action – World Stroke Organization
-
Apr 7, 2026, 16:00Amit Saraswat: The Role of Physiotherapy in Regaining Independence In Stroke Recovery
-
Apr 7, 2026, 15:59David Stegner: How Fundamental Platelet Research Can Translate Into Therapeutic Innovation
-
Apr 7, 2026, 15:58Armghan Ans: The 2026 Stroke Guidelines and the Clinical Logic Gap in AI Tools
-
Apr 7, 2026, 15:55Louise St. Germain Bannon: A Call to Advance Health Equity for Women on World Health Day
-
Apr 7, 2026, 15:54Emicizumab In a Preterm Infant with Severe Hemophilia A – RPTH
-
Apr 7, 2026, 15:45Alejandro Lusilla Lopez: PRF for Complex Anal Fistulae Outcomes